Stryker Corporation
SYKStryker Corporation (SYK) is a leading medical technology company specializing in innovative medical and surgical products, orthopedics, neurotechnology, and spine solutions. Founded in 1941, Stryker develops a wide range of devices used in hospitals and healthcare facilities worldwide to improve patient outcomes and support healthcare providers.
Dividend History
Investors can expect a dividend payout of $0.88 per share, scheduled to be distributed in 11 days on January 30, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 30, 2026 | $0.88 | 2025-12-31 | 2025-12-31 |
| October 31, 2025 | $0.84 | 2025-09-30 | 2025-09-30 |
| July 31, 2025 | $0.84 | 2025-06-30 | 2025-06-30 |
| April 30, 2025 | $0.84 | 2025-03-31 | 2025-03-31 |
| January 31, 2025 | $0.84 | 2024-12-31 | 2024-12-31 |
Dividends Summary
- Stryker Corporation has issued 71 dividend payments over the past 21 years
- The most recent dividend was paid 80 days ago, on October 31, 2025
- The highest dividend payed out to investors during this period was $0.88 per share
- The average dividend paid during this period was $0.45 per share.
Company News
The global spinal implants market was valued at USD 11.5 billion in 2024 and is projected to reach USD 15.8 billion by 2030, growing at a CAGR of 5.5%. Growth is driven by an aging global population, rising traumatic injuries, and advancements in minimally invasive spine surgery. Spinal fusion devices dominate the market, while Asia Pacific is ex...
Stryker stock rose 3.2% after Raymond James analyst Jayson Bedford upgraded it to 'outperform' and set a $418 price target, citing the company's five consecutive years of 10%+ organic revenue growth and market share gains. However, the author argues the stock is overpriced at 46x trailing earnings for merely 10% growth, disagreeing with the upgra...
Three major healthcare companies - Stryker, Amgen, and Eli Lilly - recently increased their quarterly dividends, with Amgen offering the highest dividend yield at 3.1%. Each company demonstrated strong financial performance and positive analyst outlooks for future growth.
Perimeter Medical Imaging AI reported preliminary Q2 2025 revenues of $500,000, representing 100% year-over-year growth. The company reduced operating costs by 30%, appointed new leadership, and created an Industry Advisory Board to support future growth strategies.
Stryker reported $5.42 billion in revenue for Q2 2024, a year-over-year increase of 8.5%, and EPS of $2.81 compared to $2.54 a year ago. The company's performance across various business segments and geographies was in line with or exceeded analyst estimates.
